How to buy iShares Core MSCI Total International (IXUS) ETF from India

Yes, an Indian resident can buy IXUS — legally, under the RBI's Liberalised Remittance Scheme (LRS). IXUS is iShares' Core MSCI Total International Stock ETF: ~4,400 stocks across developed and emerging markets outside the US, one ticker, 0.07%. Think hard before buying it: you already live in an emerging market, and IXUS layers multi-currency FX on an INR base.

The 30-second version

• Legal and simple. Buy IXUS via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia).
• One ticker, the world ex-US. Expense 0.07%. Tracks MSCI ACWI ex USA IMI — ~4,400 stocks, developed plus emerging, outside the US.
• Dividends matter more here. Yield ~3% — higher than US large-cap. 25% US withholding applies, reclaimable via DTAA and Form 67.
• India tax on gains: hold more than 24 months for 12.5% LTCG (no indexation); sell sooner and pay your slab rate. Section 112, not 112A.
• The trap most miss: directly-held IXUS is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax with no treaty relief. A UCITS world-ex-US ETF dodges this.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	IXUS / NYSE Arca
Issuer	iShares (BlackRock)
Expense ratio	0.07% per year
Holdings	~4,400 stocks (MSCI ACWI ex USA IMI), market-cap-weighted
Methodology	MSCI ACWI ex USA IMI Index, developed plus emerging, all-cap
Inception	October 2012
Distribution	Quarterly dividend, yield around 3%
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k means up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). File your W-8BEN during onboarding — it drops US dividend withholding from 30% to the DTAA rate of 25%. New to this? See how to invest in US stocks from India.
2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per FY). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. IXUS trades in the mid-seventy-dollar range — a whole share fits any LRS budget, or buy a fractional rupee amount.

The tax that actually matters — dividends first

IXUS distributes ~3% per year in four quarterly payouts — higher than the S&P 500, so dividend tax actually moves the after-tax return:

Step	What happens	Rate
US withholding (with W-8BEN, DTAA)	Deducted by the broker before payout	25%
India treatment	Dividend added to total income	Your slab rate
Relief	Claim the 25% US tax as foreign tax credit	Via Form 67 (TY 2025-26); Form 44 from TY 2026-27

Worked example. 100 shares at ~$75 — position ~$7,500. Annual distribution at 3% is $225. US withholds 25% = $56, you net $169. In India declare the full $225, pay at slab, claim $56 as FTC. At 30% slab, liability ~$68 — net you pay another $12. Mechanics: dividend withholding and Form 67.

Capital gains — Section 112

On sale, gains fall under Section 112 — US-listed ETFs do not get the Section 112A treatment Indian-listed equity enjoys:

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

The gain is computed in rupees — but the underlying stocks are in a dozen currencies, so you are already running a multi-currency book before the rupee leg. Model with the US capital-gains calculator; rules in how US stocks are taxed in India.

The $60,000 estate-tax trap

Directly-held IXUS is a US-situs asset — even though the underlying companies are not US-listed. Above $60,000 of US-situs assets at death, the estate faces up to 40% US estate tax, and the India-US treaty does not cover it. The fix (a UCITS world-ex-US ETF) is a choice made before the position is large. Detail: the $60,000 estate-tax trap.

What's actually in this ETF

IXUS holds ~4,400 stocks — MSCI ACWI ex USA IMI constituents — float-adjusted market-cap-weighted, rebalanced quarterly. Developed plus emerging, all-cap (IMI extends below large-cap).

Country	Approximate weight
Japan	~15%
United Kingdom	~10%
China	~8%
Canada	~8%
France	~7%
Switzerland	~6%
India	~5%
Germany	~5%
Australia	~5%
Korea, Taiwan, Netherlands, others	~31% combined

The top 10 holdings — typically TSMC, ASML, Tencent, Samsung, Novo Nordisk, Nestle, Toyota, SAP, Alibaba, AstraZeneca — are ~10% of the fund, less than half the S&P 500's ~30%. Note the India line: an Indian buying IXUS pays ~5% of every dollar to add more India on top of what they already own at home — that overlap is the main sizing question.

Alternatives — four legitimate routes to ex-US exposure

Route	Expense	What you get	Notes for an Indian investor
IXUS (US-listed, iShares)	0.07%	Developed + EM ex-US in one ticker	Default single-line ex-US holding
VXUS (US-listed, Vanguard)	0.05%	Developed + EM ex-US in one ticker	Vanguard sibling — essentially identical exposure
VEA + VWO (DIY split)	0.05% / 0.07%	Developed (VEA) and EM (VWO) separately	Lets you over- or underweight EM deliberately
UCITS ex-US ETF (Ireland)	~0.20%	Developed + EM ex-US, Ireland-domiciled	Avoids 25% US WHT and the $60k estate trap

IXUS vs VXUS is a wash — same broad index family, expense within a couple of basis points; going to the other is reasonable issuer-diversification. VEA + VWO is the route to control EM weight directly (an Indian investor often wants less EM, not more). The UCITS ex-US ETF is the structural answer at size — avoids the 25% dividend WHT and the $60k estate trap. Indian international funds are limited and expensive. See best US ETFs for Indian investors and US ETFs for Indians.

Our take

Verdict: HOLD — IXUS is single-ticker exposure to the world ex-US, useful as a diversifier against heavy US concentration but not a starter holding for an Indian investor.

• The case for. Maximum ex-US diversification in one line — developed plus emerging, ~4,400 stocks, top-10 under half the S&P 500's, at 0.07%. If you are heavily tilted to US large-cap, IXUS is the cleanest way to reduce that.
• The case against, for an Indian investor. You already live in EM India — adding ~5% India inside IXUS plus other EM is doubling down on EM, not diversifying. You are also running a multi-currency book: holdings in yen, euro, pound, yuan, won, translated to USD and then INR. Layered FX, not hedged. The ex-US-versus-US record of the last fifteen years is what it is.
• Where it fits. A diversifier sleeve once a US core is in place. Not a first US ETF. If estate-tax exposure binds, a UCITS world-ex-US ETF; if you want EM control, VEA plus VWO.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Lower expected growth than US large-cap. Ex-US has trailed the S&P 500 for most of the last fifteen years. The case for IXUS is mean reversion, not momentum.
• Multi-layer FX. Stocks in a dozen currencies, translated to USD inside the fund, then to INR for you — three currency legs, not one. See the rupee-dollar effect.
• EM regulatory and political risk. China is the largest EM weight, with policy and listing risk that has hit ex-US funds before. India inside IXUS overlaps with your home portfolio.
• Demographics. Japan and much of developed Europe sit in IXUS with structural population headwinds the index does not adjust for.

Two things people forget

• Schedule FA: disclose IXUS in Schedule FA every year you hold it — even at a loss. Non-disclosure carries Black Money Act penalties. Use the Schedule FA helper.
• Form 67 (Form 44 from TY 2026-27): file it to claim the 25% US dividend withholding as foreign tax credit. IXUS's ~3% yield makes this paperwork worth more than on a US large-cap ETF — skip it and you have paid tax twice on a meaningful dividend stream.

Bottom line

Buying IXUS from India is easy and legal. Whether you want it is the question: a higher-yield US-listed ETF (25% WHT plus Form 67), Section 112 on gains (12.5% after 24 months, not 112A), US-situs with the $60k estate trap at size — on top of multi-currency exposure and an India overlap with your home portfolio. The 0.07% expense and one-ticker breadth make it the cleanest single-line ex-US diversifier; VXUS is essentially identical; a UCITS world-ex-US ETF is the structural answer at size. For most Indian investors, IXUS belongs on a diversifier sleeve after the US core, not before. Start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.